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Abstract: The aim of this study was to assess the impact of di(n-butyl) phthalate (DBP) on the rat’s prepubertal
testis. Male Wistar rats were given daily subcutaneous injections with DBP (20 or 200 μg) or a vehicle from the
5th to the 15th postnatal day (pd). On the 16th pd, the rats were euthanized, and the testes were dissected, weighed,
and paraffin embedded. The blood was collected to determine the serum levels of testosterone (T), estradiol (E)
and FSH. The following parameters were assessed in the testis sections: diameter and length of seminiferous
tubules (st), numbers of spermatogonia A + intermediate + B (A/In/B), preleptotene spermatocytes (PL),
leptotene + zygotene + pachytene spermatocytes (L/Z/PA) and Sertoli cells per testis, percentage of st contain-
ing gonocytes or pachytene spermatocytes or lumen. An estrogenicity in vitro test was performed by means of
a transgenic yeast strain expressing human estrogen receptor alpha. At both doses, DBP had no influence on testis
and seminal vesicle weight, st diameter and length, number of germ and Sertoli cells per testis, percentage of st
containing gonocytes or pachytene spermatocytes or lumen. DBP did not change E, T or FSH serum levels. The
in vitro yeast screen showed that DBP was a weak estrogenic compound, approximately six to seven orders of
magnitude less potent than 17b-estradiol. In conclusion, exposure of a rat to DBP in doses 100 or 1,000-fold
higher than a Tolerable Daily Intake for humans had no effect on its testicular development. (Folia Histochemica
et Cytobiologica 2011; Vol. 49, No. 4, pp. 685–689)
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Introduction
Phthalates are chemicals ubiquitously employed in in-
dustry. They are commonly used as plasticizers in poly-
vinyl chloride (PCV), fixatives, detergents, lubricants,
and solvents. Thanks to such a wide range of applica-
tions, phthalates can be found in inks, lacquers, food
packaging and food products, cosmetics, and a range
of plastic products such as medical equipment and toys.
Di(n-butyl) phthalate (DBP) is a compound extensively
used in the cosmetics industry and can be found in such
products as perfumes, nail varnish and hairsprays. DBP,
diethyl phthalate and benzyl butyl phthalate metabo-
lites are found in the urine in higher amounts than other
xenoestrogens, suggesting that exposure to these three
phthalates is more significant [1]. Phthalate exposure
is possible through different ways, including the inha-
lation, dermal, oral and intravenous routes.
Numerous studies on DBP’s influence performed
on male rats during the prenatal period of life have
demonstrated the negative effect of DBP on the tes-
tis and male reproductive tract. For example, DBP
exposure in utero leads to the suppression of intrates-
ticular testosterone level, Leydig cell aggregation and
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hyperplasia, an increased number of gonocytes, and
the presence of multinucleated gonocytes in fetal tes-
tis, which is resolved in early postnatal life [2–4]. On
the other hand, Barlow and Foster [3] showed that
degeneration of the seminiferous epithelium after in
utero DBP treatment progressed towards maturity.
Additionally, fetal DBP treatment caused hypospa-
dias, cryptorchidism, prostate, epididymis and vas
deferent agenesis, decreased anogenital distance and
delayed preputial separation, suggesting diminished
testosterone action in the fetal period of life [5].
The only study to have examined DBP’s influence
on the prepubertal rat testis, performed by Kim et al.
[6], showed that a daily dose of 20 mg/animal admin-
istered from the 5th to the 14th day of life caused re-
duction of testis weight and the disruption of andro-
gen receptor (AR) and estrogen receptor (ER) con-
centration in the testes of rats aged 31 days and 42
days. The authors attributed the antiandrogenic ac-
tivity to the negative influence of DBP rather than to
the positive influence of estrogen.
Interestingly, Ge et al. [7] reported that another ph-
thalate (diethylhexyl phthalate, DEHP) had a biphasic
effect on pubertal male rats. A high DEHP dose (750
mg/kg b.w.) decreased serum testosterone levels and
delayed the onset of puberty, while low DEHP doses
(10 mg/kg b.w.) caused the opposite effect, increasing
the serum testosterone level and advancing the onset of
puberty. Estrogenic compounds are known to possess
a similar biphasic effect. Although the high doses of es-
trogenic substances have a negative impact on testis
development and initiation of spermatogenesis [8–10],
lower doses have a stimulatory effect [10–12]. The stim-
ulatory effect of estradiol on spermatogonia number/
/proliferation has been confirmed by recent studies
[13, 14]. According to studies performed by Jobling et al.
[15], DEHP is slightly estrogenic, which may explain its
stimulatory effect on spermatogonia. However, DEHP
estrogenicity has not been confirmed by other studies
[16, 17]. Similarly, some studies have confirmed DBP
estrogenicity [15–17], while others have not [18].
The aim of our study was to investigate whether
low doses of DBP can have a positive impact on testis
development, i.e. the opposite to the previously re-
ported negative influence of high doses [19].
Material and methods
Experimental set-up. Newborn male Wistar rats were used
in this study. The animal experiment was approved by the
Bioethics Committee of the Medical University of Lodz.
Animals were maintained at a stable temperature (22°C)
and a 12 hour light/12 hour dark cycle. During the acclima-
tization period (five days before mating), pregnancy and
after parturition, mothers had access to water and soy-free
food (Agropol, Poland) ad libitum. A soy-free diet is im-
portant because soya is known to be the source of estrogen-
ic substances. DBP was dissolved in dimethylosulfoxide
(DMSO) and olive oil. Newborn rats were given daily sub-
cutaneous injections with DBP 20 μg (DBP20) or DBP
200 μg (DBP200) or vehicles (C), from the 5th to the 15th post-
-natal day (pd). The volume of each injection was 0.05 ml.
All the injected substances were purchased from Sigma-
-Aldrich Co. (St. Louis, MO, USA). The autopsy was per-
formed on the 16th pd to observe the possible disturbances
caused by DBP within a short time following treatment. Such
rapid disruptive actions have previously been observed for
different xenoestrogens [8] and hormones [20]. All the sac-
rificed animals were weighed. Both testes and seminal ves-
icles were dissected, weighed, fixed in Bouin’s fluid and em-
bedded in paraffin. Blood was collected by cardiac punc-
ture, centrifuged and stored at –80°C for hormone analysis.
The experimental groups contained 20, 18, and 14 newborn
animals, respectively for C, DBP200 and DBP20 group.
Quantitative analysis of seminiferous tubules. Seminiferous
tubule examinations were performed as described previously
to assess the diameter, length and number of germ and Sertoli
cells per testis [8]. The percentage of seminiferous tubules con-
taining gonocytes (G) or spermatocytes in the pachytene stage
of first meiotic division (ScPa) or lumen was obtained by count-
ing 100 randomly-selected round seminiferous tubules. A tu-
bule was counted as positive for containing lumen if the lumen
was ≥ 10 μm in diameter. G and ScPa were distinguished based
on their morphology and location within the seminiferous ep-
ithelium. The tubule was counted as positive for G or ScPa if it
contained at least one G or ScPa, respectively.
Hormonal determinations. FSH, testosterone and estradi-
ol levels were measured in defrosted serum samples. En-
zyme Linked Immunosorbent Assay, Rat FSH Elisa
(Boicode-Hycel, Belgium) was used for the determination
of FSH with a sensitivity of 0.2 ng/ml. Concentrations of
testosterone and estradiol were determined by the compet-
itive immunoassay technique (Ortho-Clinical Diagnostic,
Amersham, UK). The sensitivities were 0.03 nmol/l for tes-
tosterone and 10.0 pmol/l for estradiol.
Yeast Estrogen Screen. Yeast Estrogen Screen (YES) is an
in vitro assay which employs a genetically modified strain of
Saccharomyces cerevisiae to assess the estrogenic potential
of compounds and their ability to interact with human es-
trogen receptor a (hERa). Normally, yeasts do not contain
ER. This strain carries an hERa gene inserted into the chro-
mosome. Moreover, it carries lacZ reporter gene integrat-
ed into multicopy plasmid. lacZ is under the control of es-
trogen responsive elements (EREs) and encodes the en-
zyme b-galactosidase. The YES assay is based on the bind-
ing of test compounds to hERa. This binding activates EREs
and induces the lacZ reporter gene. b-galactosidase is se-
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creted into the growth medium where it metabolizes the
yellow-colored substrate, CPRG (chlorophenol red-b-D-
-galactopyranoside) (Sigma Aldrich). The absorbance of the
product is measured at 540 nm.
For the purpose of this study, the test was performed
according to the modified protocol published elsewhere [21].
10 μl aliquots of 17b-estradiol and DBP dissolved in DMSO
at a range of concentrations were mixed with 190 μl of as-
say medium in microtiter plate wells. The yeast strain for
the YES assay was received from the Sub-Department of
Toxicology at Wageningen University in the Netherlands.
Statistics. Distribution of data was assessed according to
the Shapiro–Wilk’s test. One-way ANOVA followed by
a post hoc test was applied to assess the statistical significance
of the data. The Newman–Keuls test was chosen as the post
hoc test for normally distributed data (body, testis and semi-
nal vesicles weights, seminiferous tubule diameter and length,
number of germ and Sertoli cells per testis), while the
Kruskal–Wallis test was chosen for not normally distributed
data (percentage of seminiferous tubules containing G, ScPa
and lumen, serum levels of FSH, testosterone and estradiol).
Differences were considered significant at p < 0.05.
Results
Neither DBP200 nor DBP20 had any influence on the
body or testis or seminal vesicle weights, total seminif-
erous tubule length or diameter (Table 1). Similarly,
none of the DBP doses had any influence on the num-
ber of germ cells or Sertoli cells per testis, percentage
of seminiferous tubules containing G, ScPa and lumen.
Testosterone and estradiol serum levels were not in-
fluenced by DBP treatment (Table 2). FSH in the group
exposed to DBP20 was not changed in comparison with
the C group. Interestingly, blood FSH level was slightly
elevated in the group exposed to the higher DBP dose,
although this result was not statistically significant.
The Yeast Estrogen Screen showed that DBP activat-
ed the ER-mediated response in the YES assay and stim-
ulated the expression of b-galactosidase in the transgenic
yeasts. DBP was approximately six to seven orders of
magnitude less potent than 17b-estradiol (Figure 1).
Discussion
In the presented study, DBP had no effect on the
analyzed parameters of testicular development. Sper-
matogenesis advancement was not influenced by ad-
ministered DBP doses. Neither testis weight and
morphology, nor testosterone, estradiol or FSH serum
levels were affected. In the same study model, 17b-es-
tradiol, diethylstilbestrol (DES) and zearalenone
(ZEA) showed a negative impact on testicular devel-
opment even when administered in lower doses [8]. Ta
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The majority of reports on DBP’s influence on the
male reproductive tract describe treatment with doses
of around 500 mg/kg b.w. on pregnant females [3, 22, 23]
or about 1 g/kg b.w (20 mg/animal) on neonatal rats
[6] to cause adverse effects. To the best of our knowl-
edge, there have been no studies examining the in-
fluence of DBP in doses of 1 and 10 mg/kg b.w. (re-
flecting the dose of 20 and 200 μg/animal used in the
presented study) on testicular development. Based on
the previous studies where a DBP dose of 5 mg/animal
did not exert any biological effect on analyzed param-
eters (testis weight, serum testosterone level, AR and
ERb concentrations) [6], no negative impact of such
low doses should be expected. However, a study by Ge
et al. [7] suggested that besides the negative impact of
high doses, the stimulatory effect of low phthalate doses
on the onset of puberty can also be observed, as when
rats have been treated with a dose of 10 mg/kg b.w. of
DEHP, which can be compared with higher DBP dose
used in the presented study. In our study, however, this
treatment did not cause any effect.
On the other hand, DBP showed a slight estro-
genic activity in vitro. This observation is in agree-
ment with other studies [15–17], although some stud-
ies do not confirm DBP estrogenicity [18]. The pre-
sented study reveals that DBP has estrogenic poten-
tial in vitro, although its potential to induce b-galac-
tosidase synthesis in the yeast model was very weak
in comparison with 17b-estradiol.
The doses of DBP which have been proved by other
authors [3, 6, 22, 23] to have negative effects on repro-
ductive parameters were extremely high, and exceeded
the DBP estimated environmental exposure. The esti-
mated daily exposure of an average person to DBP var-
ies widely according to different studies; it approximates
to 0.007–7 μg/kg/b.w. for adults and 1.4–2.4 μg/kg/b.w.
for infants [24]. The primary source of DBP exposure is
food. According to the Ministry of Agriculture, Fisher-
ies and Food in Great Britain, the average adult DBP
exposure is 0.013–0.031 mg/person/day (equivalent of
0.2 to 0.48 μg/kg b.w./day if mean b.w. is 65 kg) [25]. In
Denmark, average daily exposure was much higher and
approximates 1.6 μg/kg b.w. in adults, 8 μg/kg b.w. in
children aged 1–6 years and 3.5 μg/kg b.w. in children
aged 7–14 years [26]. According to Blount et al. [1],
women aged 20–40 years old, who are at childbearing
age, have higher estimated exposure.
A Tolerable Daily Intake (TDI) for DBP is 10 μg/kg
b.w. This has been determined by the European
Food Safety Authority (EFSA), based on the lowest
observed adverse effect level, (LOAEL), which was
2 mg/kg b.w./day [27]. It shows that the environmental
exposure levels for DBP are below TDI. However, the
exposure reported by Müller et al. [26] was in the same
order of magnitude as TDI. Doses given to rats in this
study were two (DBP20) or three (DBP200) orders of
magnitude higher than TDI, but they had no effect on
the developing testis or hormone levels. This could lead
to the statement that DBP exposure from food, indus-
trial products and the environment does not influence
such parameters in humans or in animals.
Nonetheless, results from an experimental set-up
on rats should not be directly extrapolated into envi-
ronmental relationships. It should be kept in mind
that other parameters which were not within the scope
of this study might be affected by the abovementioned
doses of DBP. Moreover, the environmental influence
of compounds with estrogenic activity should not be
regarded as the simple effect of one compound on
the organism. For example, the mixture of DBP and
17b-estradiol had approximately additive activity in
Table 2. Results of hormonal determinations in the serum of rats aged 16 days, which were under the influence of
di(n-butyl) phthalate (DBP) 20 μg or 200 μg/animal/day from the 5th to the 15th postnatal day in comparison with the control group
Estradiol [pg/ml] Testosterone [ng/ml] FSH [ng/ml]
Control 44.6 (32.9–64.5) 1.8 (0.9–5.4) 4.9 (0.9–11.0)
DBP20 44.1 (23.7–107.4) 1.4 (0.9–4.4) 5.4 (1.7–6.8)
DBP200 74.3 (22.9–86.2) 1.9 (1.1–8.6) 6.6 (3.3–8.9)
Figure 1. Results of the Yeast Estrogen Screen (YES) assay.
b-galactosidase activity of yeast strain after treatment with
17b-estradiol (E) and di(n-butyl) phthalate (DBP).
Each value represents the mean of the three replicates
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the in vitro yeast screen [16]. The additive influence
of these compounds might be of importance even if
the exposure levels of a particular compound are be-
low the threshold of their activity.
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